Fresh Tracks Therapeutics Inc (FRTX)

1.8300
-0.1200(-6.15%)
  • Volume:
    974
  • Day's Range:
    1.8300 - 1.8300
  • 52 wk Range:
    1.6700 - 18.9450

FRTX Overview

Prev. Close
1.9001
Day's Range
1.83-1.83
Revenue
5.03M
Open
1.83
52 wk Range
1.67-18.945
EPS
-8.52
Volume
974
Market Cap
5.51M
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
84,762
P/E Ratio
-0.231
Beta
0.353
1-Year Change
-86.29%
Shares Outstanding
3,013,184
Next Earnings Date
Mar 22, 2023
What is your sentiment on Fresh Tracks Therapeutics?
or
Vote to see community's results!

Fresh Tracks Therapeutics Inc News

Fresh Tracks Therapeutics Inc Analysis

Fresh Tracks Therapeutics Inc Company Profile

Fresh Tracks Therapeutics Inc Company Profile

Employees
16

Fresh Tracks Therapeutics, Inc., a clinical-stage pharmaceutical company, engages in the development of various prescription therapeutics for the treatment of autoimmune, inflammatory, and other debilitating diseases in the United States. The company develops sofpironium bromide, which has completed Phase III clinical trials for the treatment of primary axillary hyperhidrosis; BBI-02, an oral DYRK1A inhibitor for the treatment of autoimmune and inflammatory diseases; and BBI-10, a covalent stimulator of interferon genes inhibitor for the potential treatment of autoinflammatory and rare genetic diseases, as well as next-generation kinase inhibitors. It has license and collaboration agreements with Carna Biosciences, Inc., Voronoi Inc., Bodor Laboratories, Inc. and Dr. Nicholas S. Bodor, and AnGes, Inc. The company was formerly known as Brickell Biotech, Inc. and changed its name to Fresh Tracks Therapeutics, Inc. in September 2022. Fresh Tracks Therapeutics, Inc. was founded in 2009 and is headquartered in Boulder, Colorado.

Read More

Analyst Price Target

Average3.7500 (+104.92% Upside)
High4.5
Low3
Price1.83
No. of Analysts2
Strong Sell
Sell
Neutral
Buy
Strong Buy
Buy
Analysts 12-Month Price Target

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong SellStrong SellStrong SellStrong SellStrong Sell
Technical IndicatorsSellSellStrong SellSellStrong Sell
SummaryStrong SellStrong SellStrong SellStrong SellStrong Sell
  • going back to 1$?
    0
    • why falling it is?
      0
      • they will put it down to 0.001
        0
      • after they can to buy cheaper
        0
      • Johny Cashprobably next week it will be half from today
        0
    • 0.000001
      0
      • She getting ready to pop.
        0
        • MASSIVE run incoming
          0
          • Told ya now let's see how it goes from here.
            0
            • moving on up.
              0
              • moving on up.
                0
                • moving on up.
                  0
                  • MP’s initial magnetics facility in Fort Worth, Texas, will source materials from Mountain Pass, California, restoring a fully integrated U.S. supply chainMP has entered a long-term agreement with General Motors to supply U.S.-sourced and manufactured rare earth alloy and magnets to power more than a dozen models using GM’s Ultium PlatformThe facility will produce NdFeB alloy and magnets with the potential to power approximately 500,000 EV motors per year; a gradual production ramp is expected to begin in 2023
                    0